ENVVENO MEDICAL CORPORATION

Insiders enVVeno Medical Corporation

Equities

NVNO

US29415J1060

Market Closed - Nasdaq Other stock markets 01:30:00 17/05/2024 am IST			5-day change	1st Jan Change
4.95 ^USD	-1.00%		-0.40%	-3.70%

08/05	EnVVeno Medical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
16/04	EnVVeno Medical Corporation Announces Additional Topline Efficacy Data from the VenoValve U.S. Pivotal Trial to Be Presented at the 46th Annual Charing Cross Symposium on April 24, 2024	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

EnVVeno Medical Corporation Appoints Andrew Cormack as Its Chief Commercial Officer	09/04	CI
Envveno Medical Promotes Hamed Alavi to Senior Vice President and Chief Technology Officer	18/23/18	CI
Hancock Jaffe Laboratories, Inc will Change its Name to enVVeno Medical Corporation	01/21/01	CI
Hancock Jaffe Laboratories : Will Change Name to enVVeno Medical in October	22/21/22	MT
Hancock Jaffe Laboratories, Inc. Appoints Craig Glynn Chief Financial Officer	31/20/31	CI
Hancock Jaffe Laboratories, Inc. Appoints Craig Glynn as Interim Chief Financial Officer and Interim Treasurer	11/20/11	CI
Hancock Jaffe Laboratories, Inc. Announces Resignation of Robert Rankin as Chief Financial Officer, Secretary and Treasurer	03/20/03	CI
Hancock Jaffe Laboratories, Inc. Announces Board Changes	18/19/18	CI
Hancock Jaffe Laboratories, Inc. Appoints Brian Roselauf as Director of Research and Development, Effective on June 24, 2019	20/19/20	CI
Yury Zhivilo Tenders his Resignation as Director and Chairman of Hancock Jaffe Laboratories, Inc	24/19/24	CI
Hancock Jaffe Laboratories, Inc. Announces Demise of Director, Marc Robins	30/19/30	CI
Hancock Jaffe Laboratories, Inc. Appoints Chris Sarner as Vice President of Regulatory Affairs and Quality Assurance	13/18/13	CI
Hancock Jaffe Laboratories, Inc. Announces Management Changes	02/18/02	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

BENEFIT NOW